Skip to main content

Animations

MJFF Publications

1881 - 1890 of 6420 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12329
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A Collaboration for Guiding the Rational Design of Multielement Solid Catalysts
    Journal Name: Angewandte Chemie International Edition
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/anie.202216327
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
    Journal Name: Animal Models and Experimental Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ame2.12209
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51535
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Plasma phosphorylated tau181 predicts cognitive and functional decline
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51695
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.26302
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Application of longitudinal item response theory models to modeling Parkinson’s disease progression
    Journal Name: CPT: Pharmacometrics & Systems Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/psp4.12853
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients
    Journal Name: Clinical and Translational Discovery
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/ctd2.96
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15569
    Citation Count: 4
  • Summary Details
    OPEN
    Title: European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1111/ene.15386
    Citation Count: 54
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.